Clinical Trials Browser

Phase 2 × entinostat × Dermatologic × Clear all

NCT03765229 2024-01-10

An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

Phase 2 Completed

11 enrolled 12 charts

Melanoma

NCT02697630 2023-12-08

PEMDAC

Phase 2 Completed

Uveal Melanoma

NCT00185302 2015-12-14

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Phase 2 Completed

Melanoma